Clinical trial
Combined 18F-NaF/18F-FDG PET/MRI for Detection of Skeletal Metastases
NCT00375830 · Stanford University, Other · Completed
Key facts
| NCT number | NCT00375830 |
|---|---|
| Title | Combined 18F-NaF/18F-FDG PET/MRI for Detection of Skeletal Metastases |
| Official title | Combined 18F-NaF/18F-FDG PET/MRI for Detection of Skeletal Metastases |
| Lead sponsor | Stanford University, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cancer |
| Intervention type | Drug, Procedure |
| Interventions | Bone scan, 99mTc-methyl diphosphonate, Positron Emission Tomography (PET) scan, 18F-Fludeoxyglucose (18F-FDG), Computed Tomography (CT) scan, 18F-Sodium Fluoride (18F-NaF), Whole Body Magnetic Resonance Imaging (WB-MRI) scan, Gadopentetate dimeglumine, Gadofosveset, Gadobutrol |
| Enrollment | 114 |
| Start date | Jan 1, 2006 |
| Primary completion | Apr 17, 2017 |
| Completion | Mar 14, 2019 |
| First posted | Sep 13, 2006 |
| Last update posted | Dec 12, 2023 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: